WO2013123349A1 - Methods of producing sulfilimine compounds - Google Patents

Methods of producing sulfilimine compounds Download PDF

Info

Publication number
WO2013123349A1
WO2013123349A1 PCT/US2013/026377 US2013026377W WO2013123349A1 WO 2013123349 A1 WO2013123349 A1 WO 2013123349A1 US 2013026377 W US2013026377 W US 2013026377W WO 2013123349 A1 WO2013123349 A1 WO 2013123349A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
cyanamide
hypochlorite
combining
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2013/026377
Other languages
French (fr)
Inventor
Timothy J. Adaway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corteva Agriscience LLC
Original Assignee
Dow AgroSciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP13748778.1A priority Critical patent/EP2814812B1/en
Priority to CA2863994A priority patent/CA2863994C/en
Priority to JP2014557818A priority patent/JP6138834B2/en
Priority to KR1020147025686A priority patent/KR102064827B1/en
Priority to CN201380019956.XA priority patent/CN104271555B/en
Priority to RU2014137257A priority patent/RU2634718C2/en
Priority to PL13748778T priority patent/PL2814812T3/en
Priority to ES13748778.1T priority patent/ES2625106T3/en
Priority to MX2014009922A priority patent/MX368125B/en
Application filed by Dow AgroSciences LLC filed Critical Dow AgroSciences LLC
Priority to AU2013221420A priority patent/AU2013221420B2/en
Priority to UAA201410166A priority patent/UA116628C2/en
Publication of WO2013123349A1 publication Critical patent/WO2013123349A1/en
Priority to IL233956A priority patent/IL233956B/en
Anticipated expiration legal-status Critical
Priority to IN7442DEN2014 priority patent/IN2014DN07442A/en
Priority to ZA2014/06494A priority patent/ZA201406494B/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles

Definitions

  • Embodiments of the present disclosure relate to methods of producing sulfilimine compounds, such as methods of producing sulfilimine compounds from sulfide compounds.
  • Substituted sulfilimine compounds are useful intermediates in the preparation of sulfoximine compounds, which have insecticidal activity.
  • Cyano-substituted sulfilimine compounds have been prepared by reaction of a corresponding sulfide compound with cyanamide in the presence of iodobenzene diacetate.
  • iodobenzene diacetate is expensive and causes waste disposal problems.
  • Substituted sulfilimine compounds have also been prepared by replacing the iodobenzene diacetate with hypochlorite. A corresponding sulfide compound is reacted with cyanamide in the presence of the hypochlorite. However, a corresponding sulfoxide compound is also produced as one of the reaction by-products. The yield of the substituted sulfilimine compound is affected by the amount of reaction by-products produced.
  • 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine (the sulfide compound) is oxidized to N-cyano-5'-methyl-5'-[l-(6-trifluoromethyl-3- pyridinyl)ethyl]sulfilimine (the sulfilimine compound) in the presence of sodium hypochlorite and cyanamide.
  • a by-product of the oxidation reaction is 5-[l- (methylsulfinyl)ethyl]-2-trifluoromethylpyridine (the sulfoxide compound), which may be produced at 10% or greater. It would be desirable to have a process for producing the sulfilimine compound at higher yields, such as by decreasing the amount of sulfoxide compound produced.
  • An embodiment of the present disclosure includes a method of producing a sulfilimine compound that comprises combining a sulfide compound, cyanamide, a hypochlorite compound, and a base.
  • the sulfide compound is oxidized to form a sulfilimine compound.
  • Another embodiment of the present disclosure includes a method of producing a sulfilimine compound that comprises combining a 5-[l-(alkylthio)alkyl]-2- trifluoromethylpyridine compound, cyanamide, a hypochlorite compound, and a base to form a sulfilimine compound.
  • Yet another embodiment of the present disclosure includes a method of producing N-cyano-5'-memyl-5'-[l-(6-trifluoromethyl-3 ⁇ yridinyl)ethyl]sulfilimine that comprises providing a feed stream comprising 5-[l-(methylthio)ethyl]-2- trifluoromethylpyridine and acidic impurities.
  • An aqueous cyanamide solution, an aqueous sodium hypochlorite solution, an aqueous sodium hydroxide solution, and acetonitrile are combined with the feed stream.
  • An organic phase comprising N-cyano- 5'-methyl- 1 S'-[l-(6-trifluoromethyl-3-pyridinyl)ethyl]sulfilimine is separated from an aqueous phase.
  • a method of producing a sulfilimine compound from a sulfide compound is described.
  • the method provides an increased yield of the sulfilimine compound and a decreased yield of reaction by-products.
  • the sulfilimine compound is synthesized by combining a sulfide compound, cyanamide, a hypochlorite compound, a base, and, optionally, a buffer.
  • the sulfide compound may be provided in a sulfide feed stream, which is produced by a previous reaction in the overall process of producing the sulfilimine compound.
  • the sulfide feed stream may be a feed stream from a reaction to produce the sulfide compound from a substituted enamine compound.
  • the sulfide feed stream may be produced from other types of reactions.
  • the sulfide feed stream may be used directly from the previous reaction, or may be subjected to conventional solvent exchange process, conventional solvent concentration process, or conventional purification techniques before use in the reaction to produce the sulfilimine compound.
  • the sulfide compound in the sulfide feed stream may be at least 90% pure.
  • the sulfide feed stream may also include acidic impurities, such as by-products from the previous reaction. Acidic impurities may also be present in the cyanamide.
  • the cyanamide solution and sulfide compound may be combined in the organic solvent, the base and buffer, if present, added thereto, followed by addition of the hypochlorite compound.
  • a small amount of aqueous sodium bisulfite solution may be added to the mixture to react with any excess hypochlorite compound.
  • the presence of excess hypochlorite compound may be determined by testing with starch-iodide paper.
  • an aqueous phase may be separated from an organic phase, which contains the sulfilimine compound.
  • the organic phase including the sulfilimine compound may be used directly in a subsequent oxidation to produce an insecticidal sulfoximine compound by
  • the sulfilimine compound may be isolated and purified by conventional techniques, which are not described in detail herein.
  • alkyl As used herein, the terms “alkyl,” “alkenyl,” and “alkynyl,” as well as derivative terms such as “alkoxy,” “acyl,” “alkylthio,” “arylalkyl,” “heteroarylalkyl,” and “alkylsulfonyl,” include within their scope straight chain, branched chain, or cyclic moieties. Thus, the term “alkyl” may include, but is not limited to, methyl, ethyl, 1- methylethyl, propyl, 1,1-dimethylethyl, or cyclopropyl.
  • each may be unsubstituted or substituted with one or more substituents including, but not limited to, a halogen, hydroxy, an alkoxy, an alkylthio, a C1-C6 acyl, a formyl, cyano, an aryloxy, or an aryl group, provided that the substituents are sterically compatible and the rules of chemical bonding and strain energy are satisfied.
  • substituents including, but not limited to, a halogen, hydroxy, an alkoxy, an alkylthio, a C1-C6 acyl, a formyl, cyano, an aryloxy, or an aryl group, provided that the substituents are sterically compatible and the rules of chemical bonding and strain energy are satisfied.
  • haloalkyl and haloalkenyl include alkyl and alkenyl groups substituted with from one to the maximum possible number of halogen atoms, all combinations of halogens included.
  • halogen or “halo” includes fluorine, chlorine, bromine, iodine, or combinations thereof. In one embodiment, the halogen is fluorine.
  • alkenyl and “alkynyl” are intended to include one or more unsaturated bonds.
  • aryl refers to a phenyl, indanyl, or naphthyl group.
  • heteroaryl refers to a 5- or 6-membered aromatic ring containing one or more heteroatoms, such as nitrogen, oxygen, or sulfur. These heteroaromatic rings may be fused to other aromatic systems.
  • the aryl or heteroaryl groups may be unsubstituted, or substituted with one or more substituents selected from a halogen, hydroxy, nitro, cyano, an aryloxy, fonnyl, a C]-C 6 alkyl, a C 2 -C 6 alkenyl, a C 2 -C 6 alkynyl, a C]-C 6 alkoxy, a halogenated C]-C 6 alkyl, a halogenated Ci-C 6 alkoxy, a Ci-C 6 acyl, a C1-C6 alkylthio, a Ci-C 6 alkylsulfinyl, a C1-C6 alkylsulfonyl, an aryl, a C]-C 6 OC(0)alkyl, a d-C 6 NHC(0)alkyl, C(0)OH, a d-C 6 C(0)Oalkyl, C(0)NH 2 , a C r C
  • the sulfilimine compound produced by the oxidation reaction may be a substituted sulfilimine compound, such as one of the compounds described in United States Patent No. 7,868,027, the disclosure of which is incorporated by reference herein in its entirety.
  • the sulfilimine compound may have the followin chemical structure:
  • Het is a heteroaryl group and is selected from one of the following chemical structures:
  • X is a halogen, a Q-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, NO2, SO m R6 where m is an integer from 0-2, COOR4, or CONR4R5;
  • Y is hydrogen, a halogen, a C1-C4 alkyl, a C]-C 4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C 2 -C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, N0 2 , SO m Ri where m is an integer from 0-2, COOR4, CONR4R5, aryl, or heteroaryl;
  • n is an integer from 0-3;
  • L is either a single bond, -CH(CH 2 ) P - where Rj, S, and L taken together are a 4-
  • Ri is a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-C6 alkenyl, a C3-C6 alkynyl, a C 3 -C 6 haloalkenyl, an arylalkyl, a heteroarylalkyl, or -CH 2 - in cases where Ri, S, and L taken together are a 4-, 5-, or 6-membered ring;
  • R 2 and R3 independently are hydrogen, halogen, C1-C4 alkyl, a C1-C4 haloalkyl, a C 2 -C 4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, SO m R6 where m is an integer from 0-2, COOR4, CONR4R5, an arylalkyl, a heteroarylalkyl, or R 2 and R3 and the common carbon to which they attach form a 3-6 membered ring;
  • R4 and R5 independently are hydrogen, a Q-C4 alkyl, a C1-C4 haloalkyl, a C3- C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an aryl, a heteroaryl, an arylalkyl, or a heteroarylalkyl; and
  • R6 represents a C1-C4 alkyl, a Q-C4 haloalkyl, a C3-C6 alkenyl, a C 3 -C 6 alkynyl, a C 3 -C 6 haloalkenyl, an arylalkyl, or a heteroarylalkyl.
  • the sulfilimine compound is N-cyano-iS-methyl-5'-[l-(6- trifluoromethyl-3 -pyridinyl)ethyl] sulfilimine.
  • the sulfilimine compound may be produced by reacting a corresponding sulfide compound with the hypochlorite compound, cyanamide, base, and buffer, if present.
  • the sulfide compound may have the following chemical structure:
  • the sulfide compound is a 2-trifluorometbyl-5- (l-substituted)alkylthiopyridine compound having the following chemical structure:
  • R7 and R 8 are independently H, C1-C4 alkyl, or either of R7 or R 8 taken together with R9 is a 4- to 6-membered saturated ring or R 7 taken together with R 8 is a 3- to 6-membered saturated ring optionally substituted with an O or a N atom, and R9 is a C1-C4 alkyl or R9 taken together with either of R 7 or R 8 is a 4- to 6-membered saturated ring.
  • the 2-trifluoromethyl-5-(l- substituted)alkylpyridine compound is 5-[l-(methylthio)ethyl]-2- trifluoromethylpyridine.
  • the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound is 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine and the sulfilimine compound produced therefrom is N-cyano-S-methyl-S'-fl -(6-trifluoromethyl-3- pyridinyl)ethyl] sulfilimine with 5-[l -(methylsulfinyl)-ethyl]-2-trifluoromethylpyridine potentially produced as a sulfoxide by-product of the oxidation reaction.
  • the addition of the base and buffer may reduce the amount of sulfoxide byproduct produced by the reaction.
  • the 2-trifluoromethyl-5-(l-substituted)alkylpyridine compound may be oxidized to the corresponding sulfilimine compound, which may subsequently be oxidized to produce a sulfoximine compound having insecticidal activity. While the examples herein describe the production of N-cyano-5'-methyl-5'-[l-(6-trifiuoromethyl- 3 -pyridinyl)ethyl] sulfilimine from 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine, a similar method may be used to form other sulfilimine compounds from their corresponding sulfide compounds.
  • the 2-trifluoromethyl-5-( 1 -substituted)alkylthiopyridine compound may be oxidized to the corresponding sulfilimine compound by reacting the 2-trifluoromethyl- 5-(l-substituted)-alkylthiopyridine compound, cyanamide, hypochlorite compound, base, and buffer, if present.
  • the oxidation reaction may be conducted in a suitable organic solvent that is substantially inert to the strong oxidizing conditions of the reaction and that facilitates partitioning of the resulting sulfilimine compound.
  • the organic solvent may be an aliphatic hydrocarbon, such as petroleum ether; a halogenated aliphatic or halogenated aromatic hydrocarbon, such as dichloromethane, chloroform, 1 ,2-dichloroethane, or dichlorobenzene; or an aliphatic or aromatic nitrile, such as acetonitrile (ACN) or benzonitrile.
  • the organic solvent is acetonitrile.
  • the oxidation reaction may also be conducted in a biphasic solvent system that includes a mixture of the organic solvent, such as a halogenated hydrocarbon, and water.
  • the oxidation reaction may be conducted at a temperature within a range of from about -40°C to about 30°C, such as from about - 10°C to about 10°C, or from about -5°C to about 0°C.
  • the preferred method is to slowly add the hypochlorite compound to a mixture of the 2-trifluoromethyl-5-(l- substituted)alkylthiopyridine compound, solvent, cyanamide, base, and buffer, if present.
  • the reagents, once completely mixed, may be stirred for from approximately 15 minutes to approximately 2 hours, such as for approximately 30 minutes, to provide sufficient time for the oxidation reaction to occur.
  • the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, cyanamide, base, and buffer (if present) may be combined in any order, with the hypochlorite solution being slowly added last to help control the heat of reaction.
  • the base may be added to the sulfide feed stream containing the 2- trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, followed by addition of the remaining reagents, with the hypochlorite compound added last.
  • Other addition orders are possible but precautions need to be taken to deal with unstable intermediates.
  • the base may neutralize the acidic impurities in the sulfide feed stream or in the cyanamide, enabling production of a higher yield of the sulfilimine compound.
  • the sulfide feed stream including the 2-trifluoromethyl-5-(l-substituted)alkyl- thiopyridine compound may be contacted with a solution of the base, followed by addition of the cyanamide, hypochlorite compound, and buffer (if present).
  • the sulfide feed stream may include the 2-trifluoromethy]-5-(l -substituted)alkylthiopyridine compound and acidic impurities, which may include, but are not limited to, acetic acid, hydrochloric acid, or other acidic by-products from a previous reaction.
  • the sulfide feed stream may include the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound and from about 1 x 10 "5 moles of acidic impurities to about 1 x 10 "4 moles of acidic impurities per gram.
  • the cyanamide is buffered to a pH of 4 to 5 to improve its storage stability, thus the cyanamide will add acidity to the system.
  • the base may be a suitable base of sufficient strength to neutralize the acidic impurities in the sulfide feed stream or the cyanamide.
  • the base may be added to the sulfide feed stream.
  • the base may be an alkali metal hydroxide, an alkali metal carbonate, or combinations thereof.
  • the base may be lithium hydroxide, sodium hydroxide (NaOH), potassium hydroxide, lithium carbonate, sodium carbonate, potassium carbonate, tri sodium and tripotassium phosphates, or combinations thereof.
  • the base is sodium hydroxide.
  • the base is sodium carbonate.
  • the base used in the oxidation reaction may be a solid or an aqueous solution.
  • the base may be combined with the additional reagents to neutralize the acidic impurities in the sulfide feed stream or the cyanamide.
  • the moles of base should meet or exceed the moles of acid.
  • the cyanamide used in the oxidation reaction may be a solid or an aqueous solution that includes from approximately 40% by weight to approximately 60% by weight of cyanamide.
  • the cyanamide is a solution including 50% by weight of cyanamide in water.
  • the oxidation reaction may utilize a stoichiometric amount of cyanamide relative to the 2-trifluoromethyl-5- (l -substituted)alkylthiopyridine compound, or from about 1.0 molar equivalents to about up to 1.6 molar equivalents of the cyanamide relative to the 2-trifluoromethyl-5- (l-substituted)alkylthiopyridine compound.
  • an excess of the cyanamide (relative to the 2 rifluoromethyl-5-(l -substituted)alkylthiopyridine compound) may be used.
  • the hypochlorite compound used in the oxidation reaction may be a hypochlorite solution.
  • the hypochlorite compound may be a metallic salt of hypochlorous acid.
  • the metallic salt may be a Group I alkali metal salt or a Group II alkaline earth metal salt of hypochlorous acid, such as sodium hypochlorite or calcium hypochlorite.
  • the hypochlorite solution may include the metallic salt of hypochlorous acid and water.
  • the hypochlorite solution may include from about 2% by weight to about 20% by weight of the metallic salt of hypochlorous acid, such as from about 12.5% by weight to about 17% by weight.
  • the hypochlorite solution may be commercially available, such as from Sigma- Aldrich Co. or other chemical supply company.
  • hypochlorite solution Higher concentrations of chlorine in the hypochlorite solution may be achieved by adding chlorine to the hypochlorite solution to provide a solution containing up to approximately 20% of the hypochlorite compound.
  • a stoichiometric amount of the hypochlorite compound may be utilized relative to the 2-trifluoromethyl-5-(l -substituted)alkylthiopyridine compound or from about 1.0 to about 1.2 molar equivalents of the hypochlorite compound may be used relative to the 2-trifluoromethyl-5-(l -substituted)alkylthiopyridine compound.
  • the hypochlorite solution includes 13% by weight of sodium hypochlorite. In another embodiment, the hypochlorite solution includes 15% by weight of sodium
  • hypochlorite In yet another embodiment, the hypochlorite solution includes 17% by weight of sodium hypochlorite.
  • the buffer may be a phosphate buffer, such as sodium dihydrogen phosphate.
  • the buffer may be added to the sulfide feed stream or the cyanamide.
  • the buffer may be present at from about 1 mole % to about 5 mole % relative to the 2-trifluoromethyl- 5-(l-substituted)alkylthiopyridine compound.
  • a known amount of the base may be added such that all of the phosphate buffer is in the form of disodium hydrogen phosphate or tri-sodium phosphate.
  • an aqueous phase may be separated from an organic phase, which contains the corresponding sulfilimine compound (N-cyano-»S'-methyl-5'-[l-(6-trifluoromethyl-3- pyridinyl)ethyl]sulfilimine).
  • the organic phase including the corresponding sulfilimine compound may be used directly in a subsequent reaction to produce an insecticidal sulfoximine compound by conventional techniques, or the sulfilimine compound may be isolated and purified by conventional techniques, which are not described in detail herein.
  • the use of the base and buffer, if present, in the oxidation reaction may reduce the formation of 5-[l-(methylsulfinyl)-ethyl]-2- trifluoromethylpyridine as a by-product of the oxidation reaction, resulting in an increased yield of theN-cyano-S-methyl-S-fl-Ce-trifluoromethyW- pyridinyl)ethyl] sulfilimine .
  • the pH of a mixture including the 2- trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, cyanamide, and hypochlorite compound may be determined, and then a desired amount of the base added to neutralize the mixture.
  • a sufficient amount of the base may be added to the mixture to neutralize the acidic impurities therein.
  • the mixture may be titrated with the solution of base to neutralize the acidic impurities. By first quantitating the acidity of the mixture, the mixture may be neutralized without adding excess base, which can result in incomplete conversion of the 2-trifluoromethyl-5-(l- substituted)alkylthiopyridine compound.
  • an excess of the buffer may be added to the mixture including the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound and cyanamide followed by addition of the base.
  • an excess amount of the base neutralization of the acidic impurities may be ensured without having to first measure the acidity of the mixture.
  • 5-[l -(methylthio)ethyl]-2-trifluoromethylpyridine pre-treatment The starting sulfide compound was pre-treated with base to remove acidic compounds.
  • 5-[l-methylthio)ethyl]-2-trifluoromethylpyridine was dissolved in hexane and washed with an equal volume of 1% aqueous sodium hydroxide (NaOH). The resulting organic phase was evaporated and the remaining oil used as feed for the sulfilimine reaction.
  • ACN and the sulfide feed stream (5-[l-(methylthio)ethyl]-2-trii uoromethylpyridine (94% purity)) were then added.
  • the mixture turned cloudy, indicating precipitation of some of the sodium dihydrogen phosphate.
  • the mixture was cooled to the desired reaction temperature and 1.25 molar equivalents of 13% sodium hypochlorite was slowly added. Additional oxidation reactions were conducted, adding sodium carbonate (Na 2 CC>3) or NaOH along with the sodium dihydrogen phosphate.
  • a sulfide feed stream known to include acidic impurities was titrated with dilute NaOH and found to contain about 3.2 x 10 "5 moles of acid/gram.
  • the cyanamide was titrated with dilute NaOH and found to contain about 2.01 x 10 "5 moles of acid/ gram.
  • the total moles of acid in the mixture was 0.00041 moles.
  • the effect of adding NaOH to the mixture to neutralize the acidity in the sulfide feed stream and the cyanamide was determined.
  • the NaOH was added as a 25% aqueous solution and stirred for about 5 minutes before adding the sodium hypochlorite. The results are summarized in Table 2.
  • Table 2 indicates that adding the NaOH to the mixture increased the yield of the sulfilimine compound and decreased the yield of the sulfoxide compound.
  • the effect of adding a phosphate buffer to the sulfide feed stream on the yields of sulfilimine compound and sulfoxide compound was investigated in accordance with the procedures disclosed in Example 1 using 12% aqueous sodium hypochlorite.
  • the phosphate buffer was trisodium phosphate or sodium dihydrogen phosphate, with sufficient sodium hydroxide used to generate the trisodium salt. The results are summarized in Table 3.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Description

METHODS OF PRODUCING SULFILIMINE COMPOUNDS
PRIORITY CLAIM
This application claims the benefit of U.S. Provisional Patent Application Serial No. 61/599,489, filed February 16, 2012.
TECHNICAL FIELD
Embodiments of the present disclosure relate to methods of producing sulfilimine compounds, such as methods of producing sulfilimine compounds from sulfide compounds.
BACKGROUND
Substituted sulfilimine compounds are useful intermediates in the preparation of sulfoximine compounds, which have insecticidal activity. Cyano-substituted sulfilimine compounds have been prepared by reaction of a corresponding sulfide compound with cyanamide in the presence of iodobenzene diacetate. However, iodobenzene diacetate is expensive and causes waste disposal problems.
Substituted sulfilimine compounds have also been prepared by replacing the iodobenzene diacetate with hypochlorite. A corresponding sulfide compound is reacted with cyanamide in the presence of the hypochlorite. However, a corresponding sulfoxide compound is also produced as one of the reaction by-products. The yield of the substituted sulfilimine compound is affected by the amount of reaction by-products produced. For instance, 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine (the sulfide compound) is oxidized to N-cyano-5'-methyl-5'-[l-(6-trifluoromethyl-3- pyridinyl)ethyl]sulfilimine (the sulfilimine compound) in the presence of sodium hypochlorite and cyanamide. A by-product of the oxidation reaction is 5-[l- (methylsulfinyl)ethyl]-2-trifluoromethylpyridine (the sulfoxide compound), which may be produced at 10% or greater. It would be desirable to have a process for producing the sulfilimine compound at higher yields, such as by decreasing the amount of sulfoxide compound produced. BRIEF SUMMARY
An embodiment of the present disclosure includes a method of producing a sulfilimine compound that comprises combining a sulfide compound, cyanamide, a hypochlorite compound, and a base. The sulfide compound is oxidized to form a sulfilimine compound.
Another embodiment of the present disclosure includes a method of producing a sulfilimine compound that comprises combining a 5-[l-(alkylthio)alkyl]-2- trifluoromethylpyridine compound, cyanamide, a hypochlorite compound, and a base to form a sulfilimine compound.
Yet another embodiment of the present disclosure includes a method of producing N-cyano-5'-memyl-5'-[l-(6-trifluoromethyl-3^yridinyl)ethyl]sulfilimine that comprises providing a feed stream comprising 5-[l-(methylthio)ethyl]-2- trifluoromethylpyridine and acidic impurities. An aqueous cyanamide solution, an aqueous sodium hypochlorite solution, an aqueous sodium hydroxide solution, and acetonitrile are combined with the feed stream. An organic phase comprising N-cyano- 5'-methyl-1S'-[l-(6-trifluoromethyl-3-pyridinyl)ethyl]sulfilimine is separated from an aqueous phase.
DETAILED DESCRIPTION
A method of producing a sulfilimine compound from a sulfide compound is described. The method provides an increased yield of the sulfilimine compound and a decreased yield of reaction by-products. The sulfilimine compound is synthesized by combining a sulfide compound, cyanamide, a hypochlorite compound, a base, and, optionally, a buffer. The sulfide compound may be provided in a sulfide feed stream, which is produced by a previous reaction in the overall process of producing the sulfilimine compound. By way of example, the sulfide feed stream may be a feed stream from a reaction to produce the sulfide compound from a substituted enamine compound. However, the sulfide feed stream may be produced from other types of reactions. The sulfide feed stream may be used directly from the previous reaction, or may be subjected to conventional solvent exchange process, conventional solvent concentration process, or conventional purification techniques before use in the reaction to produce the sulfilimine compound. The sulfide compound in the sulfide feed stream may be at least 90% pure. The sulfide feed stream may also include acidic impurities, such as by-products from the previous reaction. Acidic impurities may also be present in the cyanamide.
The cyanamide solution and sulfide compound may be combined in the organic solvent, the base and buffer, if present, added thereto, followed by addition of the hypochlorite compound. A small amount of aqueous sodium bisulfite solution may be added to the mixture to react with any excess hypochlorite compound. The presence of excess hypochlorite compound may be determined by testing with starch-iodide paper. After a sufficient amount of time has passed for the reagents to react, an aqueous phase may be separated from an organic phase, which contains the sulfilimine compound. The organic phase including the sulfilimine compound may be used directly in a subsequent oxidation to produce an insecticidal sulfoximine compound by
conventional techniques or the sulfilimine compound may be isolated and purified by conventional techniques, which are not described in detail herein.
As used herein, the terms "alkyl," "alkenyl," and "alkynyl," as well as derivative terms such as "alkoxy," "acyl," "alkylthio," "arylalkyl," "heteroarylalkyl," and "alkylsulfonyl," include within their scope straight chain, branched chain, or cyclic moieties. Thus, the term "alkyl" may include, but is not limited to, methyl, ethyl, 1- methylethyl, propyl, 1,1-dimethylethyl, or cyclopropyl. Unless specifically stated otherwise, each may be unsubstituted or substituted with one or more substituents including, but not limited to, a halogen, hydroxy, an alkoxy, an alkylthio, a C1-C6 acyl, a formyl, cyano, an aryloxy, or an aryl group, provided that the substituents are sterically compatible and the rules of chemical bonding and strain energy are satisfied. The terms "haloalkyl" and "haloalkenyl" include alkyl and alkenyl groups substituted with from one to the maximum possible number of halogen atoms, all combinations of halogens included. The terms "halogen" or "halo" includes fluorine, chlorine, bromine, iodine, or combinations thereof. In one embodiment, the halogen is fluorine. The terms "alkenyl" and "alkynyl" are intended to include one or more unsaturated bonds.
The term "aryl" refers to a phenyl, indanyl, or naphthyl group. The term "heteroaryl" refers to a 5- or 6-membered aromatic ring containing one or more heteroatoms, such as nitrogen, oxygen, or sulfur. These heteroaromatic rings may be fused to other aromatic systems. The aryl or heteroaryl groups may be unsubstituted, or substituted with one or more substituents selected from a halogen, hydroxy, nitro, cyano, an aryloxy, fonnyl, a C]-C6 alkyl, a C2-C6 alkenyl, a C2-C6 alkynyl, a C]-C6 alkoxy, a halogenated C]-C6 alkyl, a halogenated Ci-C6 alkoxy, a Ci-C6 acyl, a C1-C6 alkylthio, a Ci-C6 alkylsulfinyl, a C1-C6 alkylsulfonyl, an aryl, a C]-C6 OC(0)alkyl, a d-C6 NHC(0)alkyl, C(0)OH, a d-C6C(0)Oalkyl, C(0)NH2, a CrC6C(0)NHalkyl, or a Ci-C6 C(0)N(alkyl)2, provided that the substituents are sterically compatible and the rules of chemical bonding and strain energy are satisfied.
The sulfilimine compound produced by the oxidation reaction may be a substituted sulfilimine compound, such as one of the compounds described in United States Patent No. 7,868,027, the disclosure of which is incorporated by reference herein in its entirety. By way of example, the sulfilimine compound may have the followin chemical structure:
Figure imgf000005_0001
where "Het" is a heteroaryl group and is selected from one of the following chemical structures:
Figure imgf000006_0001
Figure imgf000006_0002
X is a halogen, a Q-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, NO2, SOmR6 where m is an integer from 0-2, COOR4, or CONR4R5;
Y is hydrogen, a halogen, a C1-C4 alkyl, a C]-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, N02, SOmRi where m is an integer from 0-2, COOR4, CONR4R5, aryl, or heteroaryl;
n is an integer from 0-3;
L is either a single bond, -CH(CH2)P- where Rj, S, and L taken together are a 4-
, 5-, or 6-membered ring, and p is an integer from 1-3, -CH(CH2OCH2)- where Ri, S, and L taken together are a 6-membered ring, or -CH- where L, R2, and the common carbon to which they connect taken together are a 4-, 5-, or 6-membered ring with up to, but no more than, 1 heteroatom; Ri is a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an arylalkyl, a heteroarylalkyl, or -CH2- in cases where Ri, S, and L taken together are a 4-, 5-, or 6-membered ring;
R2 and R3 independently are hydrogen, halogen, C1-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, SOmR6 where m is an integer from 0-2, COOR4, CONR4R5, an arylalkyl, a heteroarylalkyl, or R2 and R3 and the common carbon to which they attach form a 3-6 membered ring;
R4 and R5 independently are hydrogen, a Q-C4 alkyl, a C1-C4 haloalkyl, a C3- C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an aryl, a heteroaryl, an arylalkyl, or a heteroarylalkyl; and
R6 represents a C1-C4 alkyl, a Q-C4 haloalkyl, a C3-C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an arylalkyl, or a heteroarylalkyl.
In one embodiment, the sulfilimine compound is N-cyano-iS-methyl-5'-[l-(6- trifluoromethyl-3 -pyridinyl)ethyl] sulfilimine.
The sulfilimine compound may be produced by reacting a corresponding sulfide compound with the hypochlorite compound, cyanamide, base, and buffer, if present. The sulfide compound ma have the following chemical structure:
Figure imgf000007_0001
where Het, Ri, R2, R3, and L are defined as previously discussed, and n is an integer from 0-3. In one embodiment, the sulfide compound is a 2-trifluorometbyl-5- (l-substituted)alkylthiopyridine compound having the following chemical structure:
Figure imgf000007_0002
where R7 and R8 are independently H, C1-C4 alkyl, or either of R7 or R8 taken together with R9 is a 4- to 6-membered saturated ring or R7 taken together with R8 is a 3- to 6-membered saturated ring optionally substituted with an O or a N atom, and R9 is a C1-C4 alkyl or R9 taken together with either of R7 or R8 is a 4- to 6-membered saturated ring. In one embodiment, the 2-trifluoromethyl-5-(l- substituted)alkylpyridine compound is 5-[l-(methylthio)ethyl]-2- trifluoromethylpyridine.
In one embodiment, the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound is 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine and the sulfilimine compound produced therefrom is N-cyano-S-methyl-S'-fl -(6-trifluoromethyl-3- pyridinyl)ethyl] sulfilimine with 5-[l -(methylsulfinyl)-ethyl]-2-trifluoromethylpyridine potentially produced as a sulfoxide by-product of the oxidation reaction. However, the addition of the base and buffer, if present, may reduce the amount of sulfoxide byproduct produced by the reaction.
The 2-trifluoromethyl-5-(l-substituted)alkylpyridine compound may be oxidized to the corresponding sulfilimine compound, which may subsequently be oxidized to produce a sulfoximine compound having insecticidal activity. While the examples herein describe the production of N-cyano-5'-methyl-5'-[l-(6-trifiuoromethyl- 3 -pyridinyl)ethyl] sulfilimine from 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine, a similar method may be used to form other sulfilimine compounds from their corresponding sulfide compounds.
The 2-trifluoromethyl-5-( 1 -substituted)alkylthiopyridine compound may be oxidized to the corresponding sulfilimine compound by reacting the 2-trifluoromethyl- 5-(l-substituted)-alkylthiopyridine compound, cyanamide, hypochlorite compound, base, and buffer, if present. The oxidation reaction may be conducted in a suitable organic solvent that is substantially inert to the strong oxidizing conditions of the reaction and that facilitates partitioning of the resulting sulfilimine compound. By way of example, the organic solvent may be an aliphatic hydrocarbon, such as petroleum ether; a halogenated aliphatic or halogenated aromatic hydrocarbon, such as dichloromethane, chloroform, 1 ,2-dichloroethane, or dichlorobenzene; or an aliphatic or aromatic nitrile, such as acetonitrile (ACN) or benzonitrile. In one embodiment, the organic solvent is acetonitrile. The oxidation reaction may also be conducted in a biphasic solvent system that includes a mixture of the organic solvent, such as a halogenated hydrocarbon, and water. The oxidation reaction may be conducted at a temperature within a range of from about -40°C to about 30°C, such as from about - 10°C to about 10°C, or from about -5°C to about 0°C. The preferred method is to slowly add the hypochlorite compound to a mixture of the 2-trifluoromethyl-5-(l- substituted)alkylthiopyridine compound, solvent, cyanamide, base, and buffer, if present. The reagents, once completely mixed, may be stirred for from approximately 15 minutes to approximately 2 hours, such as for approximately 30 minutes, to provide sufficient time for the oxidation reaction to occur.
The 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, cyanamide, base, and buffer (if present) may be combined in any order, with the hypochlorite solution being slowly added last to help control the heat of reaction. By way of example, the base may be added to the sulfide feed stream containing the 2- trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, followed by addition of the remaining reagents, with the hypochlorite compound added last. Other addition orders are possible but precautions need to be taken to deal with unstable intermediates. The base may neutralize the acidic impurities in the sulfide feed stream or in the cyanamide, enabling production of a higher yield of the sulfilimine compound.
The sulfide feed stream including the 2-trifluoromethyl-5-(l-substituted)alkyl- thiopyridine compound may be contacted with a solution of the base, followed by addition of the cyanamide, hypochlorite compound, and buffer (if present). The sulfide feed stream may include the 2-trifluoromethy]-5-(l -substituted)alkylthiopyridine compound and acidic impurities, which may include, but are not limited to, acetic acid, hydrochloric acid, or other acidic by-products from a previous reaction. The sulfide feed stream may include the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound and from about 1 x 10"5 moles of acidic impurities to about 1 x 10"4 moles of acidic impurities per gram. The cyanamide is buffered to a pH of 4 to 5 to improve its storage stability, thus the cyanamide will add acidity to the system.
The base may be a suitable base of sufficient strength to neutralize the acidic impurities in the sulfide feed stream or the cyanamide. The base may be added to the sulfide feed stream. The base may be an alkali metal hydroxide, an alkali metal carbonate, or combinations thereof. By way of example, the base may be lithium hydroxide, sodium hydroxide (NaOH), potassium hydroxide, lithium carbonate, sodium carbonate, potassium carbonate, tri sodium and tripotassium phosphates, or combinations thereof. In one embodiment, the base is sodium hydroxide. In another embodiment, the base is sodium carbonate. The base used in the oxidation reaction may be a solid or an aqueous solution. The base may be combined with the additional reagents to neutralize the acidic impurities in the sulfide feed stream or the cyanamide. The moles of base should meet or exceed the moles of acid.
The cyanamide used in the oxidation reaction may be a solid or an aqueous solution that includes from approximately 40% by weight to approximately 60% by weight of cyanamide. In one embodiment, the cyanamide is a solution including 50% by weight of cyanamide in water. In a particular embodiment, the oxidation reaction may utilize a stoichiometric amount of cyanamide relative to the 2-trifluoromethyl-5- (l -substituted)alkylthiopyridine compound, or from about 1.0 molar equivalents to about up to 1.6 molar equivalents of the cyanamide relative to the 2-trifluoromethyl-5- (l-substituted)alkylthiopyridine compound. To ensure complete conversion of the 2- trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, an excess of the cyanamide (relative to the 2 rifluoromethyl-5-(l -substituted)alkylthiopyridine compound) may be used.
The hypochlorite compound used in the oxidation reaction may be a hypochlorite solution. The hypochlorite compound may be a metallic salt of hypochlorous acid. The metallic salt may be a Group I alkali metal salt or a Group II alkaline earth metal salt of hypochlorous acid, such as sodium hypochlorite or calcium hypochlorite. The hypochlorite solution may include the metallic salt of hypochlorous acid and water. The hypochlorite solution may include from about 2% by weight to about 20% by weight of the metallic salt of hypochlorous acid, such as from about 12.5% by weight to about 17% by weight. The hypochlorite solution may be commercially available, such as from Sigma- Aldrich Co. or other chemical supply company. Higher concentrations of chlorine in the hypochlorite solution may be achieved by adding chlorine to the hypochlorite solution to provide a solution containing up to approximately 20% of the hypochlorite compound. In particular embodiments, a stoichiometric amount of the hypochlorite compound may be utilized relative to the 2-trifluoromethyl-5-(l -substituted)alkylthiopyridine compound or from about 1.0 to about 1.2 molar equivalents of the hypochlorite compound may be used relative to the 2-trifluoromethyl-5-(l -substituted)alkylthiopyridine compound. To ensure complete conversion of the 2-trifluoromethyl-5-(l -substituted)alkylthiopyridine compound, an excess of the hypochlorite (relative to the 2-trifluoromethyl-5-(l - substituted)alkylthiopyridine compound) may be used. In one embodiment, the hypochlorite solution includes 13% by weight of sodium hypochlorite. In another embodiment, the hypochlorite solution includes 15% by weight of sodium
hypochlorite. In yet another embodiment, the hypochlorite solution includes 17% by weight of sodium hypochlorite.
The buffer may be a phosphate buffer, such as sodium dihydrogen phosphate.
The buffer may be added to the sulfide feed stream or the cyanamide. The buffer may be present at from about 1 mole % to about 5 mole % relative to the 2-trifluoromethyl- 5-(l-substituted)alkylthiopyridine compound. After addition of the buffer, a known amount of the base may be added such that all of the phosphate buffer is in the form of disodium hydrogen phosphate or tri-sodium phosphate.
After a sufficient amount of time has passed for the reagents to react, an aqueous phase may be separated from an organic phase, which contains the corresponding sulfilimine compound (N-cyano-»S'-methyl-5'-[l-(6-trifluoromethyl-3- pyridinyl)ethyl]sulfilimine). The organic phase including the corresponding sulfilimine compound may be used directly in a subsequent reaction to produce an insecticidal sulfoximine compound by conventional techniques, or the sulfilimine compound may be isolated and purified by conventional techniques, which are not described in detail herein. The use of the base and buffer, if present, in the oxidation reaction may reduce the formation of 5-[l-(methylsulfinyl)-ethyl]-2- trifluoromethylpyridine as a by-product of the oxidation reaction, resulting in an increased yield of theN-cyano-S-methyl-S-fl-Ce-trifluoromethyW- pyridinyl)ethyl] sulfilimine .
In an additional embodiment, the pH of a mixture including the 2- trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, cyanamide, and hypochlorite compound may be determined, and then a desired amount of the base added to neutralize the mixture. By way of example, a sufficient amount of the base may be added to the mixture to neutralize the acidic impurities therein. The mixture may be titrated with the solution of base to neutralize the acidic impurities. By first quantitating the acidity of the mixture, the mixture may be neutralized without adding excess base, which can result in incomplete conversion of the 2-trifluoromethyl-5-(l- substituted)alkylthiopyridine compound.
In another embodiment, an excess of the buffer may be added to the mixture including the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound and cyanamide followed by addition of the base. By adding an excess amount of the base, neutralization of the acidic impurities may be ensured without having to first measure the acidity of the mixture.
The following examples serve to explain embodiments of the present disclosure in more detail. These examples are not to be construed as being exhaustive or exclusive as to the scope of this invention.
Examples
Example 1
Preparation of N-cyano-5'-methyl-5,-[l-(6-trifluoromethyl-3- pyridinyl)ethyl]sulfilirnine:
5-[l -(methylthio)ethyl]-2-trifluoromethylpyridine pre-treatment The starting sulfide compound was pre-treated with base to remove acidic compounds. 5-[l-methylthio)ethyl]-2-trifluoromethylpyridine was dissolved in hexane and washed with an equal volume of 1% aqueous sodium hydroxide (NaOH). The resulting organic phase was evaporated and the remaining oil used as feed for the sulfilimine reaction. The above treated 5-[l-methylthio)ethyl]-2- trifluoromethylpyridine, 10.6g (about 0.045 moles) was mixed with 39.2g of acetonitrile and 5.06g (0.059 moles) of 50% aqueous cyanamide in a 250 ml flask equipped with electric stirrer (half moon agitator), thermowell, nitrogen pad, and addition funnel. Using a bath the flask was cooled to -7°C. A 6.14% solution of sodium hypochlorite (68. l g, 0.056 moles) was slowly added over 88 minutes, keeping the temperature at -7°C. After a 35 minute post reaction period the excess oxidizing agents were quenched with sodium bisulfite to give a negative test to starch-iodide paper. The mixture was warmed to room temperature and phase separated. The total accountability as the sulfilimine in the two phases was 90.1% and the total accountability as the sulfoxide was 10.1%. Without first treating the 5-[l- methylthio)ethyl]-2-trifluoromethylpyridine with the hexane and base, the
accountibilities of the sulfilimine and sulfoxide respectively were 85.6% and 13.7%. Example 2
Preparation of N-cyano-5'-methyl-5'-[l-(6-trifluoromethyl-3- pyridinyl)ethyl]sulfilimine: sodium dihydrogen phosphate and base addition An acid (sodium dihydrogen phosphate) was added to the mixture to simulate the effects of low levels of acid in the sulfide feed stream. Cyanamide (1.4 molar equivalents relative to the 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine), water, and 2 mole% of the sodium dihydrogen phosphate were mixed until homogeneous. ACN and the sulfide feed stream (5-[l-(methylthio)ethyl]-2-trii uoromethylpyridine (94% purity)) were then added. The mixture turned cloudy, indicating precipitation of some of the sodium dihydrogen phosphate. The mixture was cooled to the desired reaction temperature and 1.25 molar equivalents of 13% sodium hypochlorite was slowly added. Additional oxidation reactions were conducted, adding sodium carbonate (Na2CC>3) or NaOH along with the sodium dihydrogen phosphate. All oxidation reactions used 1.4 molar equivalents of cyanamide and 1.25 molar equivalents of 13% sodium hypochlorite relative to the 5-[l-(methylthio)ethyl]-2- trifluoromethylpyridine. All runs resulted in 99+% conversion of the 5-[l- (methylthio)ethyl]-2-trifluoromethylpyridine to reaction products. The results are summarized in Table 1.
Table 1
Figure imgf000013_0001
The addition of the sodium dihydrogen phosphate to the mixture almost doubled the amount of sulfoxide compound (5-[l-(methylsulfinyl)ethyl]-2- trifluoromethylpyridine) produced, thus reducing the yield of sulfilimine compound (N-cyano-S-methyl-S-IT -(6-trifluoromethyl-3-pyridinyl)ethyl] sulfilimine) by around 5%. The addition of the sodium carbonate had minimal effect. The addition of the sodium hydroxide increased the yield of sulfilimine compound to approximately the same as the baseline or even slightly better. The results in Table 1 indicate that the addition of NaOH to the sulfide feed stream contaminated with acids increased the yield of sulfilimine compound.
Example 3
Preparation of N-cyano-1S-methyl-5'-[l-(6-trifluoromethyl-3- pyridinyl)ethyl] sulfilimine: base addition
A sulfide feed stream known to include acidic impurities was titrated with dilute NaOH and found to contain about 3.2 x 10"5 moles of acid/gram. The cyanamide was titrated with dilute NaOH and found to contain about 2.01 x 10"5 moles of acid/ gram. Thus, for the oxidation reaction of 5-[l-(methylthio)ethyl]-2- trifluoromethylpyridine with cyanamide and sodium hypochlorite (13%) conducted on a 0.047 mole scale, the total moles of acid in the mixture was 0.00041 moles. The effect of adding NaOH to the mixture to neutralize the acidity in the sulfide feed stream and the cyanamide was determined. The NaOH was added as a 25% aqueous solution and stirred for about 5 minutes before adding the sodium hypochlorite. The results are summarized in Table 2.
Table 2
Figure imgf000014_0001
Table 2 indicates that adding the NaOH to the mixture increased the yield of the sulfilimine compound and decreased the yield of the sulfoxide compound.
Example 4
Preparation of N-cyano-.S'-methyl-i'-fl-ie-trifluoromethyl-S- pyridinyl)ethyl] sulfilimine :
buffer addition
The effect of adding a phosphate buffer to the sulfide feed stream on the yields of sulfilimine compound and sulfoxide compound was investigated in accordance with the procedures disclosed in Example 1 using 12% aqueous sodium hypochlorite. The phosphate buffer was trisodium phosphate or sodium dihydrogen phosphate, with sufficient sodium hydroxide used to generate the trisodium salt. The results are summarized in Table 3.
Table 3
Figure imgf000015_0001
The addition of the phosphate buffer to the sulfide feed stream resulted in an increased yield of sulfilimine compound, as evidenced in Table 3 by the difference in average sulfimine compound yield between the runs including the phosphate buffer compared to those lacking the phosphate buffer.
The effect on yields of the sulfilimine compound and sulfoxide compound by varying the amount of phosphate buffer used was also investigated. The phosphate buffer was added in such a way as to produce trisodium phosphate. The results are summarized in Table 4.
Table 4
Figure imgf000015_0002
A positive effect of adding the phosphate buffer to the sulfide feed stream was seen in the range of evaluated 1 -5 mole% of phosphate buffer relative to the sulfide compound. While the invention may be susceptible to various modifications and alternative forms, specific embodiments have been described by way of example in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the following appended claims and their legal equivalents.

Claims

CLAIMS What is claimed is:
1. A method of producing a sulfilimine compound, comprising:
combining a sulfide compound, cyanamide, a hypochlorite compound, and a base; and oxidizing the sulfide compound to form a sulfilimine compound.
2. The method of claim 1, further comprising adding a buffer to the sulfide compound, cyanamide, hypochlorite compound, and base.
3. The method of claim 1, wherein combining a sulfide compound, cyanamide, a hypochlorite compound, and a base comprises combining the cyanamide, hypochlorite compound, and base with a sulfide compound having the chemical structure:
Figure imgf000017_0001
wherein Het is a moiety selected from the group consisting of
Figure imgf000018_0001
Figure imgf000018_0002
X is a moiety selected from the group consisting of a halogen, a C1-C4 alkyl, a Q-C4 haloalkyl, a
C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy,
CN, N02, SOmR6 where m is an integer from 0-2, COOR4, and CONR4R5; Y is a moiety selected from the group consisting of hydrogen, a halogen, a CrC4 alkyl, haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C C4 alkoxy, a C1-C4
haloalkoxy, CN, N02, SOmRi where m is an integer from 0-2, COOR4, CONR4R5, aryl, and
heteroaryl;
n is an integer from 0-3; L is either a single bond, -CH(CH2)p- where R], S, and L taken together are a 4-, 5-, or 6-membered
ring and p is an integer from 1-3, -CH(CH2OCH2)- where Ri, S, and L taken together are a
6-membered ring, or -CH- where L, R2, and the common carbon to which they connect
taken together are a 4-, 5-, or 6-membered ring with up to, but no more than, 1 heteroatom;
Ri is a moiety selected from the group consisting of a Q-C4 alkyl, a C1-C4 haloalkyl, a C3-C6
alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an arylalkyl, a heteroarylalkyl, or -CH2- in
cases where Ri, S, and L taken together are a 4-, 5-, or 6-membered ring;
each of R2 and R3 is independently selected from the group consisting of hydrogen, halogen, C1-C4
alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C]-C4
alkoxy, a C]-C4 haloalkoxy, CN, SOmR6 where m is an integer from 0-2, COOR4,
CONR4R5, an arylalkyl, a heteroarylalkyl, or R2 and R3 and the common carbon to which
they attach form a 3-6 membered ring;
each of R4 and R5 is independently selected from the group consisting of hydrogen, a C1-C4 alkyl, a
C1-C4 haloalkyl, a C3-C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an aryl, a heteroaryl,
an arylalkyl, or a heteroarylalkyl; and
R¾ is a moiety selected from the group consisting of a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-C6
alkenyl, a C3-C6 alkynyl, a C3-C haloalkenyl, an arylalkyl, and a
heteroarylalkyl.
4. The method of claim 1, wherein combining a sulfide compound, cyanamide, a hypochlorite compound, and a base comprises combining the sulfide compound, cyanamide, hypochlorite compound, and a base selected from the group consisting of an alkali metal hydroxide, an alkali phosphate, an alkali metal carbonate, and combinations thereof.
5. The method of claim 1, wherein combining a sulfide compound, cyanamide, a hypochlorite compound, and a base to form a sulfilimine compound comprises reacting the sulfide compound, cyanamide, hypochlorite compound, and base at a temperature from about -40°C to about 30°C.
6. A method of producing a sulfilimine compound, comprising:
combining a 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, cyanamide, a
hypochlorite compound, and a base to form a sulfilimine compound.
7. The method of claim 6, wherein combining a 2-trifluoromethyl-5-(l - substituted)alkylthiopyridine compound, cyanamide, a hypochlorite compound, and a base comprises combining the cyanamide, hypochlorite compound, and base with a 2- trifluoromethyl-5-(l-substituted)alkylthiopyridine compound of the following formula:
Figure imgf000020_0001
, wherein each of R7 and Rg is independently selected from the group consisting of hydrogen, Cj-C4 alkyl, either of R7 or Rg taken together with R9 is a 4- to 6-membered saturated ring or R7 taken together with Rs is a 3- to 6- membered saturated ring optionally substituted with an O or a N atom, and R9 is a Cj- C4 alkyl or R9 taken together with either of R7 or Rg is a 4- to 6-membered saturated ring.
8. The method of claim 6, wherein combining a 2-trifluoromethyl-5-(l- substituted)alkylthiopyridine compound, cyanamide, a hypochlorite compound, and a base comprises combining the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, cyanamide, a hypochlorite compound solution comprising from about 2% by weight to about 20% by weight of a metallic salt of hypochlorous acid, and the base.
9. The method of claim 6, wherein combining a 2-trifluoromethyl-5-(l - substituted)alkylthiopyridine compound, cyanamide, a hypochlorite compound, and a base comprises combining the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, an aqueous cyanamide solution, an aqueous solution of the hypochlorite compound, and the base.
10. The method of claim 6, wherein combining a 2-trifluoromethyl-5-(l- substituted)alkylthiopyridine compound, cyanamide, a hypochlorite compound, and a base comprises combining the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, cyanamide, the hypochlorite compound, and an alkali metal hydroxide, an alkali metal carbonate, or combinations thereof.
11. The method of claim 6, wherein combining a 2-trifluoromethyl-5-( 1 - substituted)alkylthiopyridine compound, cyanamide, a hypochlorite compound, and a base comprises combining 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine, cyanamide, sodium hypochlorite, and sodium hydroxide to form the sulfilimine compound.
12. The method of claim 6, wherein combining a 2-trifluoromethyl-5-(l- substituted)alkylthiopyridine compound, cyanamide, a hypochlorite compound, and a base comprises combining 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine, cyanamide, sodium hypochlorite, and sodium carbonate to form the sulfilimine compound.
13. The method of claim 6, further comprising adding a phosphate buffer to the feed stream.
14. A method of producing N-cyano-5,-methyl-5-[l-(6-trifluoromethyl-3- pyridinyl)ethyl]sulfilimine, comprising:
providing a feed stream comprising 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine and acidic
impurities;
combining an aqueous cyanamide solution, an aqueous sodium hypochlorite solution, an aqueous
sodium hydroxide solution, and acetonitrile with the feed stream; and separating an organic phase comprising N-cyano-5'-methyl-5,-[l-(6-trifluoromethyl-3- pyridinyl)ethyl]sulfilimine from an aqueous phase.
15. The method of claim 14, wherein providing a feed stream comprising 5- [l-(memylthio)ethyl]-2-trifluoromethylpyridine and acidic impurities comprises providing the feed stream comprising 5-[l-(methylthio)ethyl]-2- trifluoromethylpyridine and from about 1 x 10"5 moles of acidic impurities to about 1 x 10"4 moles of acidic impurities per gram of feed.
16. The method of claim 14, wherein combining an aqueous cyanamide solution, an aqueous sodium hypochlorite solution, an aqueous sodium hydroxide solution, and acetonitrile with the feed stream comprises combining the aqueous cyanamide solution, an aqueous sodium hypochlorite solution comprising from about 12.5% by weight to about 17% by weight of sodium hypochlorite, an aqueous sodium hydroxide solution, and acetonitrile with the feed stream.
17. The method of claim 14, wherein combining an aqueous cyanamide solution, an aqueous sodium hypochlorite solution, an aqueous sodium hydroxide solution, and acetonitrile with the feed stream comprises combining the aqueous cyanamide solution, an aqueous sodium hypochlorite solution comprising from about 12.5% by weight to about 20% by weight of sodium hypochlorite, an aqueous sodium hydroxide solution, and acetonitrile with the feed stream.
18. The method of claim 14, wherein combining an aqueous cyanamide solution, an aqueous sodium hypochlorite solution, an aqueous sodium hydroxide solution, and acetonitrile with the feed stream comprises combining from about 1.0 molar equivalents to about 1.6 molar equivalents of cyanamide relative to the 5-[l- (methylthio)ethyl]-2-trifluoromethylpyridine, from about 1.0 to about 1.2 molar equivalents of sodium hypochlorite relative to the 5-[l-(methylthio)ethyl]-2- trifluoromethylpyridme, the aqueous sodium hydroxide solution, and acetonitrile with the feed stream.
19. The method of claim 18, wherein molar ratio of cyanamide to sodium hypochlorite is about 1.2.
20. A method of producing a sulfilimine compound, comprising combining a 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, cyanamide, a hypochlorite compound solution, and a base at a temperature from about -40°C to about 30°C to form a sulfilimine compound, wherein the hypochlorite compound solution comprises from about 2% by weight to about 20% by weight of a metallic salt of hypochlorous acid.
PCT/US2013/026377 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds Ceased WO2013123349A1 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
MX2014009922A MX368125B (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds.
JP2014557818A JP6138834B2 (en) 2012-02-16 2013-02-15 Method for producing sulfilimine compound
KR1020147025686A KR102064827B1 (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds
CN201380019956.XA CN104271555B (en) 2012-02-16 2013-02-15 The method for preparing sulfilimine compound
RU2014137257A RU2634718C2 (en) 2012-02-16 2013-02-15 Method for sulphylimin compounds production
PL13748778T PL2814812T3 (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds
ES13748778.1T ES2625106T3 (en) 2012-02-16 2013-02-15 Production methods of sulfilimine compounds
EP13748778.1A EP2814812B1 (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds
AU2013221420A AU2013221420B2 (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds
CA2863994A CA2863994C (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds
UAA201410166A UA116628C2 (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds
IL233956A IL233956B (en) 2012-02-16 2014-08-05 Methods of producing sulfilimine compounds
IN7442DEN2014 IN2014DN07442A (en) 2012-02-16 2014-09-04
ZA2014/06494A ZA201406494B (en) 2012-02-16 2014-09-04 Methods of producing sulfilimine compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261599489P 2012-02-16 2012-02-16
US61/599,489 2012-02-16

Publications (1)

Publication Number Publication Date
WO2013123349A1 true WO2013123349A1 (en) 2013-08-22

Family

ID=48982761

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/026377 Ceased WO2013123349A1 (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds

Country Status (19)

Country Link
US (2) US9227936B2 (en)
EP (1) EP2814812B1 (en)
JP (1) JP6138834B2 (en)
KR (1) KR102064827B1 (en)
CN (1) CN104271555B (en)
AR (1) AR090076A1 (en)
AU (1) AU2013221420B2 (en)
BR (1) BR102013003576B8 (en)
CA (1) CA2863994C (en)
CO (1) CO7081159A2 (en)
ES (1) ES2625106T3 (en)
IL (1) IL233956B (en)
IN (1) IN2014DN07442A (en)
MX (1) MX368125B (en)
PL (1) PL2814812T3 (en)
RU (1) RU2634718C2 (en)
UA (1) UA116628C2 (en)
WO (1) WO2013123349A1 (en)
ZA (1) ZA201406494B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140163236A1 (en) * 2012-12-11 2014-06-12 Dow Agrosciences Llc Process for the preparation of certain substituted sulfilimines
WO2025017547A1 (en) 2023-07-18 2025-01-23 Adama Makhteshim Ltd. Method for preparing an n-cyano sulfilimine compound
US12384777B2 (en) 2019-04-24 2025-08-12 Tay Therapeutics Limited Compounds comprising N-methyl-2-pyridone, and pharmaceutically acceptable salts

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9745292B2 (en) 2014-03-13 2017-08-29 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing CFTR activity
WO2015138909A1 (en) 2014-03-13 2015-09-17 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing cftr activity
EP3157917B1 (en) 2014-06-19 2020-03-18 Proteostasis Therapeutics, Inc. Compounds, compositions and methods of increasing cftr activity
US10738011B2 (en) 2014-12-23 2020-08-11 Proteostasis Therapeutics, Inc. Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
US10344023B2 (en) 2014-12-23 2019-07-09 Proteostasis Therapeutics, Inc. Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis
MA41253A (en) 2014-12-23 2017-10-31 Proteostasis Therapeutics Inc COMPOUNDS, COMPOSITIONS AND PROCESSES TO INCREASE THE ACTIVITY OF CFTR
US10392378B2 (en) 2014-12-23 2019-08-27 Proteostasis Therapeutics, Inc. Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis
US10548878B2 (en) 2015-07-24 2020-02-04 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods of increasing CFTR activity
BR112018007021B1 (en) 2015-10-06 2024-01-09 Proteostasis Therapeutics, Inc Compound, composition comprising said compounds and use thereof to treat cystic fibrosis
MA43775A (en) 2016-04-07 2021-05-05 Proteostasis Therapeutics Inc ANALOGUES OF IVACAFTOR CONTAINING SILICON ATOMS
TWI735573B (en) * 2016-06-21 2021-08-11 美商陶氏農業科學公司 Methods of manufacturing certain substituted sulfilimines
MA45397A (en) 2016-06-21 2019-04-24 Proteostasis Therapeutics Inc COMPOUNDS, COMPOSITIONS AND PROCESSES TO INCREASE THE ACTIVITY OF CFTR

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973148A (en) * 1996-11-13 1999-10-26 Dow Agrosciences Llc N-arylsulfilimine compounds and their use as catalysts in the preparation of N-arylarylsulfonamide compounds
US20050228027A1 (en) * 2004-04-08 2005-10-13 Yuanming Zhu Insecticidal N-substituted sulfoximines
US20080207910A1 (en) * 2007-02-26 2008-08-28 Dow Agrosciences Llc Process for the preparation of certain substituted sulfilimines

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2573733A (en) * 1950-01-03 1951-11-06 Celanese Corp Production of anthraquinone dyestuffs
US4085093A (en) 1976-07-23 1978-04-18 The Goodyear Tire & Rubber Company Sulfilimines as premature vulcanization inhibitors
FR2723370B1 (en) * 1994-08-02 1996-09-13 Roussel Uclaf NEW IMIDAZOLE DERIVATIVES, THEIR PREPARATION PROCESS, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TWI387585B (en) 2006-09-01 2013-03-01 Dow Agrosciences Llc Insecticidal n-substituted (heteroaryl)alkyl sulfilimines
TWI383970B (en) * 2006-11-08 2013-02-01 Dow Agrosciences Llc Multi-substituted pyridyl sulfoximines and their use as insecticides
MX2010000593A (en) * 2007-07-20 2010-08-04 Dow Agrosciences Llc Increasing plant vigor.
JP5320460B2 (en) * 2008-05-01 2013-10-23 ダウ アグロサイエンシィズ エルエルシー Synergistic insecticidal mixture
WO2011023677A1 (en) * 2009-08-26 2011-03-03 Novartis Ag Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators
MX2015007372A (en) * 2012-12-11 2015-09-23 Dow Agrosciences Llc Improved process for the preparation of|n-cyano-s-[1 -(pyridin-3-yl)ethyl]-s-methylsulfilimines.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973148A (en) * 1996-11-13 1999-10-26 Dow Agrosciences Llc N-arylsulfilimine compounds and their use as catalysts in the preparation of N-arylarylsulfonamide compounds
US20050228027A1 (en) * 2004-04-08 2005-10-13 Yuanming Zhu Insecticidal N-substituted sulfoximines
US20080207910A1 (en) * 2007-02-26 2008-08-28 Dow Agrosciences Llc Process for the preparation of certain substituted sulfilimines
US7868027B2 (en) 2007-02-26 2011-01-11 Dow Agrosciences Llc Process for the preparation of certain substituted sulfilimines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2814812A4

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140163236A1 (en) * 2012-12-11 2014-06-12 Dow Agrosciences Llc Process for the preparation of certain substituted sulfilimines
WO2014093276A1 (en) * 2012-12-11 2014-06-19 Dow Agrosciences Llc Improved process for the preparation of|n-cyano-s-[1 -(pyridin-3-yl)ethyl]-s-methylsulfilimines
US12384777B2 (en) 2019-04-24 2025-08-12 Tay Therapeutics Limited Compounds comprising N-methyl-2-pyridone, and pharmaceutically acceptable salts
WO2025017547A1 (en) 2023-07-18 2025-01-23 Adama Makhteshim Ltd. Method for preparing an n-cyano sulfilimine compound

Also Published As

Publication number Publication date
PL2814812T3 (en) 2017-10-31
JP6138834B2 (en) 2017-05-31
US20160046580A1 (en) 2016-02-18
RU2634718C2 (en) 2017-11-03
AU2013221420A1 (en) 2014-09-25
US9884824B2 (en) 2018-02-06
AR090076A1 (en) 2014-10-15
AU2013221420B2 (en) 2017-07-13
JP2015507018A (en) 2015-03-05
US9227936B2 (en) 2016-01-05
CA2863994C (en) 2020-06-16
IL233956A0 (en) 2014-09-30
BR102013003576B8 (en) 2022-10-11
KR102064827B1 (en) 2020-01-13
CO7081159A2 (en) 2014-10-10
ES2625106T3 (en) 2017-07-18
MX368125B (en) 2019-09-19
US20130217883A1 (en) 2013-08-22
EP2814812B1 (en) 2017-03-29
CN104271555A (en) 2015-01-07
EP2814812A4 (en) 2015-07-01
BR102013003576B1 (en) 2019-09-17
RU2014137257A (en) 2016-04-10
BR102013003576A2 (en) 2015-06-16
IN2014DN07442A (en) 2015-04-24
ZA201406494B (en) 2016-12-21
IL233956B (en) 2018-08-30
CA2863994A1 (en) 2013-08-22
UA116628C2 (en) 2018-04-25
MX2014009922A (en) 2014-11-21
KR20140127320A (en) 2014-11-03
EP2814812A1 (en) 2014-12-24
CN104271555B (en) 2017-06-06

Similar Documents

Publication Publication Date Title
AU2013221420B2 (en) Methods of producing sulfilimine compounds
NZ600119A (en) Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives
US8962850B2 (en) Nitrogen-containing heterocyclic compound and method for producing same
WO2014089385A3 (en) Methods of synthesizing a prostacyclin analog
EP1985610A1 (en) Improved method for producing nitroisourea derivative
KR20150064749A (en) Process for preparing alkoxycarbonyl isothiocyanate
KR101292750B1 (en) Novel method for preparing 1-oxacephalosporin derivatives
JP2011016782A (en) Method for producing glycolic acid, and glycolic acid-containing composition
JP6477187B2 (en) Process for producing 2-amino-6-methylnicotinic acid ester
AU2014201037B2 (en) Nitrogen-containing heterocyclic compound and method for producing same
JP2017202992A (en) Method for producing (trifluoromethyl)malonic acid ester
RU2459815C1 (en) Method of producing 1-cyclohexene-1,2-dicarboxylic acid derivatives
JPH0662539B2 (en) Method for producing 2,3-dicyano-1,4-dihydroxynaphthalene derivative
JP2005306743A (en) Method for preparing alkylaminopyridines
EP3472135A1 (en) Method for the preparation of 3-(trifluoromethyl)pyrazine-2-carboxylic acid esters

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13748778

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 233956

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2863994

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2014557818

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: MX/A/2014/009922

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: IDP00201405384

Country of ref document: ID

ENP Entry into the national phase

Ref document number: 20147025686

Country of ref document: KR

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2013748778

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 14203659

Country of ref document: CO

Ref document number: A201410166

Country of ref document: UA

Ref document number: 2013748778

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014137257

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2013221420

Country of ref document: AU

Date of ref document: 20130215

Kind code of ref document: A